Wedbush Securities’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $252K | Sell |
533
-227
| -30% | -$114K | 0.01% | 996 |
|
|
2025
Q4 | $355K | Sell |
760
-505
| -40% | -$234K | 0.01% | 812 |
|
|
2025
Q3 | $539K | Buy |
1,265
+50
| +4% | +$19.4K | 0.02% | 637 |
|
|
2025
Q2 | $465K | Buy |
1,215
+508
| +72% | +$183K | 0.02% | 658 |
|
|
2025
Q1 | $244K | Sell |
707
-87
| -11% | -$28K | 0.01% | 912 |
|
|
2024
Q4 | $238K | Buy |
794
+127
| +19% | +$44.4K | 0.01% | 945 |
|
|
2024
Q3 | $271K | Sell |
667
-658
| -50% | -$241K | 0.01% | 846 |
|
|
2024
Q2 | $426K | Sell |
1,325
-25
| -2% | -$8.12K | 0.02% | 688 |
|
|
2024
Q1 | $450K | Buy |
+1,350
| New | +$413K | 0.02% | 684 |
|
|
2023
Q1 | – | Sell |
-874
| Closed | -$210K | – | 1099 |
|
|
2022
Q4 | $210K | Buy |
+874
| New | +$196K | 0.01% | 891 |
|
|
2022
Q2 | – | Sell |
-973
| Closed | -$244K | – | 1118 |
|
|
2022
Q1 | $244K | Buy |
973
+4
| +0.4% | +$1K | 0.01% | 898 |
|
|
2021
Q4 | $249K | Sell |
969
-69
| -7% | -$16.9K | 0.01% | 961 |
|
|
2021
Q3 | $252K | Buy |
1,038
+12
| +1% | +$2.93K | 0.01% | 950 |
|
|
2021
Q2 | $212K | Sell |
1,026
-42
| -4% | -$8.56K | 0.01% | 1033 |
|
|
2021
Q1 | $201K | Buy |
+1,068
| New | +$188K | 0.01% | 985 |
|
|
2020
Q2 | – | Sell |
-5,267
| Closed | -$473K | – | 980 |
|
|
2020
Q1 | $473K | Sell |
5,267
-120
| -2% | -$15.5K | 0.06% | 369 |
|
|
2019
Q4 | $796K | Buy |
5,387
+27
| +0.5% | +$3.63K | 0.07% | 316 |
|
|
2019
Q3 | $645K | Buy |
5,360
+52
| +1% | +$6.72K | 0.06% | 349 |
|
|
2019
Q2 | $717K | Sell |
5,308
-236
| -4% | -$29.8K | 0.07% | 311 |
|
|
2019
Q1 | $723K | Buy |
5,544
+844
| +18% | +$113K | 0.08% | 301 |
|
|
2018
Q4 | $585K | Buy |
+4,700
| New | +$631K | 0.07% | 306 |
|
|
2018
Q2 | – | Sell |
-5,247
| Closed | -$509K | – | 893 |
|
|
2018
Q1 | $509K | Buy |
5,247
+103
| +2% | +$9.99K | 0.07% | 361 |
|
|
2017
Q4 | $452K | Sell |
5,144
-90
| -2% | -$7.23K | 0.06% | 414 |
|
|
2017
Q3 | $417K | Sell |
5,234
-794
| -13% | -$63.9K | 0.05% | 448 |
|
|
2017
Q2 | $526K | Buy |
6,028
+88
| +1% | +$7.45K | 0.07% | 374 |
|
|
2017
Q1 | $529K | Buy |
5,940
+123
| +2% | +$10.3K | 0.07% | 344 |
|
|
2016
Q4 | $431K | Buy |
+5,817
| New | +$436K | 0.06% | 375 |
|
Other funds holding HCA
VCM
VPM
Wedbush Securities's HCA Position: Q1 2026 in Review
Wedbush Securities reduced its HCA Healthcare (HCA) stake by 30% in Q1 2026, selling an estimated $114K and leaving 533 shares worth $252K. The position accounts for 0.01% of the portfolio, ranked #996.
Wedbush Securities first reported a position in HCA in Q4 2016 and has held it in 27 quarters since. The position peaked at $796K in Q4 2019. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Wedbush Securities held 533 shares of HCA Healthcare worth $252K as of Q1 2026.
- Wedbush Securities sold 227 HCA Healthcare shares in Q1 2026, an estimated $114K.
- HCA Healthcare made up 0.01% of Wedbush Securities's portfolio in Q1 2026, its #996 holding.
- Wedbush Securities first reported a position in HCA Healthcare in Q4 2016 and has held it in 27 quarters since.
- Wedbush Securities's HCA Healthcare position peaked at $796K in Q4 2019.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.